Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescentsDaniel Leung, YL Lau, Samuel M. S. Cheng et al.|Frontiers in Immunology|2023Cited by 9
Population-based sero-epidemiological estimates of real-world vaccine effectiveness against Omicron infection in an infection-naive population, Hong Kong, January to July 2022Jonathan J. Lau, Joseph T. Wu, Samuel M. S. Cheng et al.|medRxiv|2022Cited by 5